Group 1 - The company, Saifen Technology, announced on October 27 that it recognized a total asset impairment loss and credit impairment loss of 11.5415 million yuan for the first three quarters of 2025, which reduced the total consolidated profit for the same period by the same amount [1] - The asset impairment provision was not audited by an accounting firm [1]

Core Insights - The company reported a revenue of 302 million yuan for the first three quarters of 2025, representing a year-on-year growth of 38.39% [1] - The net profit attributable to shareholders reached 93.21 million yuan, marking a year-on-year increase of 71.07% [1] - The net profit excluding non-recurring items was 84.93 million yuan, reflecting a year-on-year growth of 57.26% [1] - The basic earnings per share stood at 0.2268 yuan [1]

Group 1 - The company reported a third-quarter revenue of 120 million yuan, representing a year-on-year increase of 81.39% [1] - The net profit attributable to shareholders reached 39.55 million yuan, showing a year-on-year growth of 141.05% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 38.43 million yuan, with a year-on-year increase of 141.46% [1] - The basic earnings per share were 0.0950 yuan [1]

证券代码：688758 证券简称：赛分科技 公告编号：2025-038 苏州赛分科技股份有限公司 关于2025年前三季度计提资产减值准备的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、计提资产减值准备情况的概述 根据《企业会计准则》及相关会计政策的规定，为客观、公允地反映苏州赛 分科技股份有限公司（以下简称"公司"）截至 2025 年 9 月 30 日的财务状况及 2025 年前三季度的经营成果，本着谨慎性原则，公司对截至 2025 年 9 月 30 日 公司及子公司的资产进行了减值测试，对可能发生资产减值损失的相关资产计提 了减值准备。公司 2025 年前三季度计提各项资产减值准备合计 1,154.15 万元， 具体如下表： | 序号 | 类别 | 项目 | 计提金额 | | --- | --- | --- | --- | | 1 | 信用减值损失 | 应收账款坏账损失 | 564.72 | | | | 其他应收款坏账损失 | 1.83 | | | 小计 | | 566.54 | | 2 | 资产减值损失 | ...

Financial Performance - The company's operating revenue for Q3 2025 reached ¥119,788,506.40, representing an increase of 81.39% compared to the same period last year[3] - Total profit for the quarter was ¥45,199,489.74, a significant increase of 144.48% year-over-year[3] - Net profit attributable to shareholders was ¥39,552,647.11, reflecting a growth of 141.05% compared to the previous year[3] - The basic earnings per share for the quarter was ¥0.0950, up 112.12% from the same period last year[4] - The company reported a total profit for the year-to-date of ¥108,079,853.83, which is a 66.04% increase compared to the same period last year[3] - Total operating revenue for the first three quarters of 2025 reached ¥302,421,404.15, a significant increase of 38.3% compared to ¥218,532,533.42 in the same period of 2024[17] - Net profit for the first three quarters of 2025 was ¥93,645,705.20, up 68.5% from ¥55,561,721.27 in the first three quarters of 2024[18] - Operating profit increased to ¥108,154,429.72, representing a growth of 65.5% compared to ¥65,356,259.75 in the previous year[18] - The total comprehensive income for the first three quarters of 2025 was ¥91,960,348.22, compared to ¥54,042,954.92 in the same period of 2024, reflecting a growth of 70.3%[19] - Basic earnings per share for the first three quarters of 2025 were ¥0.2268, up from ¥0.1487 in the previous year, marking a 52.5% increase[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,427,105,125.21, an increase of 20.70% from the end of the previous year[4] - As of September 30, 2025, the total assets of Suzhou Saifen Technology Co., Ltd. amounted to ¥1,427,105,125.21, an increase from ¥1,182,310,293.37 as of December 31, 2024, reflecting a growth of approximately 20.7%[12] - The company's current assets reached ¥858,561,819.92, compared to ¥590,390,238.19 in the previous year, indicating a year-over-year increase of about 45.4%[12] - Total liabilities increased to ¥96,998,335.76, up from ¥84,269,862.24, reflecting a growth of 15%[14] - The company's total equity attributable to shareholders reached ¥1,319,690,139.06, a rise of 21.2% from ¥1,088,064,865.48 year-over-year[14] - The total liabilities of the company are not explicitly stated, but the increase in current liabilities, particularly accounts payable, which decreased from ¥13,091,433.61 to ¥7,108,618.89, indicates a strategic management of payables[12] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥45,456,049.79, down 16.34% compared to the previous year[3] - Cash inflow from operating activities was ¥274,608,565.13, compared to ¥241,262,774.62 in the same period last year, indicating a growth of 13.8%[22] - The net cash flow from operating activities was $45,456,049.79, a decrease of 16.5% compared to $54,336,238.00 in the previous period[23] - Cash outflow from operating activities totaled $229,152,515.34, an increase of 22.4% from $186,926,536.62[23] - Cash inflow from investment activities totaled $144,242,198.75, down 34.6% from $220,728,330.02 in the prior period[23] - The net cash flow from investment activities was -$136,696,544.55, worsening from -$121,957,503.69 year-over-year[23] - Total cash inflow from financing activities was $210,595,309.31, significantly higher than $3,212,779.50 in the previous period[23] - The net cash flow from financing activities improved to $157,771,514.06 from -$6,886,002.91 in the prior period[23] - The ending cash and cash equivalents balance increased to $167,895,271.06, compared to $92,106,811.04 at the end of the previous period[23] Research and Development - Research and development expenses totaled ¥16,699,960.62 for the quarter, accounting for 13.94% of operating revenue, a decrease of 3.89 percentage points year-over-year[4] - Research and development expenses rose to ¥40,600,253.46, an increase of 20.3% from ¥33,730,244.06 in the same period last year[17] - The company has focused on enhancing product performance and core technology through independent research and development, driving growth in both new and existing customer projects[7] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 7,159[9] - The company has not reported any significant changes in shareholder structure or related party transactions during the reporting period[11] Product and Technology - There are no new product launches or technological advancements mentioned in the conference call, focusing instead on financial performance and asset management strategies[11]

Core Insights - On October 16, 2023, Saifen Technology's stock rose by 9.02%, with a trading volume of 255 million yuan [1] - The company recorded a net financing purchase of 11.97 million yuan on the same day, with a total financing balance of 54.82 million yuan, representing 6.93% of its market capitalization [1][2] Financial Performance - For the period from January to June 2025, Saifen Technology achieved a revenue of 183 million yuan, reflecting a year-on-year growth of 19.76% [2] - The net profit attributable to the parent company for the same period was 53.66 million yuan, marking a year-on-year increase of 40.91% [2] Shareholder Information - As of June 30, 2025, the number of shareholders in Saifen Technology was 10,500, a decrease of 4.63% from the previous period [2] - The average number of circulating shares per shareholder increased by 4.86% to 3,779 shares [2] - The company has distributed a total of 27.90 million yuan in dividends since its A-share listing [3] Institutional Holdings - As of June 30, 2025, the largest circulating shareholder was Southern Science and Technology Innovation Board 3-Year Open Mixed Fund, holding 791,100 shares, a decrease of 893,600 shares from the previous period [3] - Galaxy Medical Mixed A Fund has exited the list of the top ten circulating shareholders [3]

Core Viewpoint - On October 16, 2023, Saifen Technology (688758) closed at 18.62 yuan, marking a 9.02% increase with a trading volume of 2.55 billion yuan and a turnover rate of 31.31% [2][3] Trading Activity - The stock was the only one listed on the daily trading leaderboard due to its turnover rate exceeding 30% [2] - The top five trading departments accounted for a total transaction amount of 73.50 million yuan, with a net buying amount of 16.64 million yuan [2] - The largest buying department was Guotai Junan Securities Headquarters, with a purchase amount of 12.79 million yuan, followed by Guotai Junan Securities Chengdu Longteng East Road with 10.17 million yuan [3] Fund Flow - The stock experienced a net inflow of 12.68 million yuan from main funds throughout the day [3] - The top buying departments included: - Guotai Junan Securities Headquarters: 12.79 million yuan - Guotai Junan Securities Chengdu Longteng East Road: 10.17 million yuan - Goldman Sachs (China) Securities Shanghai Pudong New Area: 8.82 million yuan [3] - The top selling department was Dongwu Securities Suzhou Xiangcheng Cailian Road with a selling amount of 8.96 million yuan [3]

Core Insights - The chemical pharmaceutical sector experienced a slight increase of 0.45% on October 16, with Sunflower leading the gains [1] - The Shanghai Composite Index closed at 3916.23, up 0.1%, while the Shenzhen Component Index closed at 13086.41, down 0.25% [1] Stock Performance - Sunflower (300111) saw a closing price of 9.00, with a significant increase of 10.97% and a trading volume of 4.1856 million shares, amounting to a transaction value of 36.12 billion [1] - Duorui Pharmaceutical (301075) closed at 50.80, up 10.63%, with a trading volume of 74,600 shares and a transaction value of 3.72 billion [1] - Asia-Pacific Pharmaceutical (002370) closed at 7.55, up 10.06%, with a trading volume of 185,700 shares and a transaction value of 1.40 billion [1] - Other notable gainers include Luoxin Pharmaceutical (002793) with a 9.94% increase and a closing price of 5.53, and Saifen Technology (688758) with a 9.02% increase and a closing price of 18.62 [1] Fund Flow Analysis - The chemical pharmaceutical sector experienced a net outflow of 18.2269 million from institutional investors, while retail investors saw a net outflow of 83.7 billion [2] - Conversely, speculative funds recorded a net inflow of 855 million [2] Individual Stock Fund Flow - Shutaishen (300204) had a net inflow of 123 million from institutional investors, while retail investors experienced a net outflow of 22.4 million [3] - Baijishenzhou (688235) saw a net inflow of 123 million from institutional investors but a net outflow of 118 million from speculative funds [3] - Xingqi Eye Medicine (300573) recorded a net inflow of 87.1576 million from institutional investors, with retail investors facing a net outflow of 73.7128 million [3]

Core Points - The Shanghai Composite Index closed at 3916.23 points, above the five-day moving average, with a slight increase of 0.10% [1] - The total trading volume of A-shares reached 1,948.66 billion yuan [1] - A total of 282 A-shares have surpassed the five-day moving average, with notable stocks showing significant deviation rates [1] Summary by Category Stock Performance - The stocks with the highest deviation rates from the five-day moving average include: - Xiangnong Chip (300475) with a deviation rate of 9.93% and a daily increase of 16.70% [1] - Yingjixin (688209) with a deviation rate of 8.92% and a daily increase of 14.24% [1] - Luchang Technology (002813) with a deviation rate of 8.00% and a daily increase of 9.98% [1] Trading Activity - The trading turnover rates for the top stocks with significant price movements include: - Xiangnong Chip at 15.82% [1] - Yingjixin at 12.53% [1] - Luchang Technology at 4.44% [1] Additional Notable Stocks - Other stocks that recently crossed the five-day moving average with smaller deviation rates include: - Yuyue Medical (乖离率较小) [1] - Donggang Shares (乖离率较小) [1] - Fangzheng Electric (乖离率较小) [1]

Core Points - The Shanghai Composite Index is at 3910.12 points, slightly down by 0.05%, and above the five-day moving average [1] - The total trading volume of A-shares today is 15,714.28 billion yuan, with 268 A-shares breaking through the five-day moving average [1] Summary by Category Stock Performance - Notable stocks with significant deviation from the five-day moving average include: - Yingjixin (688209) with a deviation rate of 10.48% and a daily increase of 16.34% [1] - Shannon Chip (300475) with a deviation rate of 10.38% and a daily increase of 17.30% [1] - Wanma Technology (300698) with a deviation rate of 8.70% and a daily increase of 12.09% [1] - Other stocks with smaller deviation rates include: - Meidixi, Ruifeng New Materials, and Tongrentang, which have just crossed the five-day moving average [1] Trading Data - The trading data for stocks that broke through the five-day moving average includes: - Yingjixin: Latest price 24.42 yuan, five-day moving average 22.10 yuan, turnover rate 10.83% [1] - Shannon Chip: Latest price 105.22 yuan, five-day moving average 95.33 yuan, turnover rate 14.24% [1] - Wanma Technology: Latest price 50.61 yuan, five-day moving average 46.56 yuan, turnover rate 16.94% [1]